Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMountview Est. Regulatory News (MTVW)

Share Price Information for Mountview Est. (MTVW)

Share Price is delayed by 15 minutes
Get Live Data
9,000.00    0.00 (0.00%)
Bid:
8,800.00
Ask:
9,000.00
Spread: 200.00 (2.273%)
Market Cap: £350.91m
MTVW Live PriceLast checked at - London Stock Exchange

Intraday Mountview Est. Share Chart

Interim Results

30 Nov 2010 09:00

RNS Number : 9952W
Mountview Estates PLC
30 November 2010
 



Chairman's Statement

 

On the following pages are the unaudited Accounts for the six months ended 30 September 2010. Revenue is down by only 4% whereas earnings per share are down by nearly 8.5%. This is explained almost entirely by the increase in finance and administrative costs.

 

The new government has been in office for six months and much has been said about cuts in government spending and increases in taxation. Apart from the increase in value added tax to 20% from the beginning of January the finer detail of most of the other measures has yet to be published. It appears that the impact of these measures will be in 2011/2012 and subsequent financial years and so it is reasonable to believe that the second half of the company's financial year can be as good as the first half.

 

Inflation is now above 3% and this may necessitate the raising of base rate and it is still difficult for first time buyers to get mortgages and therefore trading conditions could be difficult during 2011. Nevertheless the further repayment of nearly £10 million of borrowings over the last six months has put the company in a strong financial position with about £40 million available to invest and we hope to take advantage of good purchasing opportunities during the next eighteen months thus ensuring good profits in years to come.

 

Jacqueline Murphy resigned as a director and left the company as at 31 August 2010. It is never the right time for a valued employee to depart but it does give an ideal opportunity for the company to review its procedures and introduce any desired changes.

 

With effect from 1 November 2010 Alistair Sinclair has been appointed a non-executive director of the company. Alistair is the son of the late Frank Sinclair, who co-founded the company, and his 34 years of experience in the banking industry will provide an invaluable contribution to the company.

 

The interim dividend is maintained at 50 pence per share and will be payable on 28 March 2011 to shareholders on the register at 25 February 2011.

 

 

 

GROUP INCOME STATEMENT (UNAUDITED)

 

 

Half year

ended

30.09.2010

£000

Half year

ended

30.09.2009

£000

Year

ended

31.03.2010

£000

Revenue

24,265

25,274

56,697

Cost of Sales

(9,091)

(9,382)

(22,191)

Gross Profit

15,174

15,892

34,506

Administrative expenses

(1,782)

(1,487)

(4,046)

Operating profit before changes in

fair value of investment properties

13,392

14,405

30,460

Increase in fair value of investments

-

-

2,142

 

Profit from operations

13,392

14,405

32,602

Net finance costs

(1,751)

(1,560)

(3,347)

Profit before taxation

11,641

12,845

29,255

 

Taxation - current

(3,604)

(3,700)

(7,969)

Taxation - deferred

443

112

349

 

Taxation

(3,161)

(3,588)

(7,620)

 

Profit attributable to equity shareholders

8,480

9,257

21,635

 

Basic and diluted earnings per share (pence)

217.5p

237.4p

554.8p

 

 

 

All items within the consolidated income statement relate to continuing operations.

 

 

GROUP STATEMENT OF FINANCIAL POSITION (UNAUDITED)

 

As at

As at

As at

30.09.2010

30.09.2009

31.03.2010

£000

£000

£000

Assets

Non-current assets

Property plant and equipment

2,453

2,499

2,422

Investment properties

32,348

31,916

32,872

34,801

34,415

35,294

Current assets

Inventories of trading properties

252,966

263,254

256,964

Trade and other receivables

1,738

881

1,197

Cash and cash equivalents

115

238

443

254,819

264,373

258,604

 

Total assets

289,620

298,788

293,898

 

Equity and liabilities

 

Capital and reserves attributable

to equity holders of the company

 

Share capital

195

195

195

Capital redemption reserve

55

55

55

Capital reserve

25

25

25

Other reserve

56

56

56

Cash flow hedge reserve

(3,640)

(3,119)

(3,640)

Retained earnings

210,363

195,937

206,366

 

 

207,054

193,149

203,057

Non-current liabilities

Long-term borrowings

55,000

76,000

65,000

Deferred tax

7,713

8,394

8,157

62,713

84,394

73,157

Current liabilities

Bank overdrafts and loans

11,768

13,906

8,876

Trade and other payables

920

502

1,355

Current tax payable

3,525

3,718

3,813

Derivative financial instruments

3,640

3,119

3,640

 

19,853

21,245

17,684

 

Total liabilities

82,566

105,639

90,841

 

Total equity and liabilities

289,620

298,788

293,898

 

 

GROUP CASHFLOW STATEMENT (UNAUDITED)

 

 

Half year

Half year

Year

ended

ended

ended

30.09.2010

30.09.2009

31.03.2010

£000

£000

£000

Cash flows from operating activities

Profit from operations

13,392

14,405

32,602

Adjustment for:

Depreciation

75

76

156

(Gain)/Loss on disposal of property, plant and equipment

 

(17)

 

-

 

5

(Increase) in fair value of investment properties

-

-

(2,142)

Cash flow from operations before movement

in working capital

13,450

14,481

30,621

Decrease in inventories

3,999

5,552

11,841

(Increase) in receivables

(541)

(221)

(538)

(Decrease) in payables

(488)

(1,556)

(822)

Cash generated from operations

16,420

18,256

41,102

 

Interest paid

(1,751)

(1,564)

(3,347)

Income taxes paid

(3,891)

(2,356)

(6,410)

Net cash inflow from operating activities

 

10,778

 

14,336

 

31,345

 

Investing activities

Proceeds from disposal of investment properties

1,100

650

1,895

Proceeds from disposal of property, plant and equipment

 

39

 

-

 

-

Purchase of property, plant and equipment

(129)

(7)

(11)

Capital expenditure on investment properties

(525)

(371)

(434)

Net cash inflow from investing activities

485

272

1,450

 

Cash flows from financing activities

 

Repayment of borrowings

(9,800)

(12,700)

(23,800)

Equity dividend paid

(4,483)

(4,093)

(6,042)

Net cash (outflow) from financing activities

(14,283)

(16,793)

(29,842)

 

Net (decrease)/increase in cash and cash equivalents

 

(3,020)

 

(2,185)

 

2,953

 

Opening cash and cash equivalents

(8,258)

(11,211)

(11,211)

Closing cash and cash equivalents

(11,278)

(13,396)

(8,258)

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

 

 

 

Half year

Half year

Year

ended

ended

ended

30.09.2010

30.09.2009

31.03.2010

£000

£000

£000

Shareholders' funds as at the beginning of the period

 

203,057

 

187,490

 

187,490

Profit for the period

8,480

9,257

21,635

Change in fair value of cash flow hedge

-

495

(26)

Dividends

(4,483)

(4,093)

(6,042)

Shareholders' funds at the end of the period

207,054

193,149

203,057

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

 

 

 

Half year

Half year

Year

ended

ended

ended

30.09.2010

30.09.2009

31.03.2010

£000

£000

£000

Profit for the year

8,480

9,257

21,635

Change in fair value of cash flow hedge

-

495

(26)

Total recognised income

8,480

9,752

21,609

The total recognised income

in the year is attributable to:

Equity shareholders of the parent

 

 

8,480

 

 

9,752

 

 

21,609

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR FEWFIUFSSEIF
Date   Source Headline
26th May 202610:27 amRNSUpdate on General Meeting voting outcome
20th Apr 202611:00 amRNSHolding(s) in Company
20th Apr 202610:59 amRNSHolding(s) in Company
20th Apr 202610:58 amRNSHolding(s) in Company
31st Mar 202611:05 amRNSDirector/PDMR Shareholding
30th Mar 20266:30 pmRNSDividend Payment Delay
25th Mar 20265:04 pmRNSDirector/PDMR Shareholding
25th Mar 202610:01 amRNSDirector/PDMR Shareholding
19th Mar 202610:02 amRNSDirector/PDMR Shareholding
18th Mar 202612:29 pmRNSDirector/PDMR Shareholding
25th Feb 20264:21 pmRNSDirector/PDMR Shareholding
23rd Feb 202612:49 pmRNSDirector/PDMR Shareholding
12th Feb 202612:03 pmRNSDirector/PDMR Shareholding
10th Feb 20264:28 pmRNSDirector/PDMR Shareholding
9th Feb 202611:16 amRNSDirector/PDMR Shareholding
26th Jan 20263:38 pmRNSBoard Committee change
22nd Dec 202511:40 amRNSDirector/PDMR Shareholding
22nd Dec 202511:40 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSUnaudited Interim Results for 6m ended 30 Sep 2025
17th Nov 202512:15 pmRNSResult of General Meeting
22nd Oct 202512:00 pmRNSNotice of General Meeting
17th Oct 202512:22 pmRNSDirector/PDMR Shareholding
16th Oct 20251:04 pmRNSDirector/PDMR Shareholding
15th Oct 20254:29 pmRNSDirector/PDMR Shareholding
1st Oct 20251:16 pmRNSDirector/PDMR Shareholding
15th Aug 20257:03 amRNSBoard changes
13th Aug 20251:46 pmRNSResult of Annual General Meeting
30th Jul 20255:10 pmRNS2025 Annual Report and Accounts
24th Jul 202512:32 pmRNSDirector/PDMR Shareholding
22nd Jul 20251:05 pmRNSDirector/PDMR Shareholding
17th Jul 20255:20 pmRNSDirector/PDMR Shareholding
11th Jul 202511:22 amRNSPublication of 2025 Annual Report & Notice of AGM
19th Jun 20257:00 amRNSPreliminary Results: year ended 31 March 2025
16th May 20257:00 amRNSUpdate on General Meeting voting outcome
31st Mar 20257:00 amRNSDirectorate change – Contract Extension
26th Mar 202512:02 pmRNSDirector/PDMR Shareholdings
28th Feb 20255:25 pmRNSDirector/PDMR Shareholding
14th Feb 20257:00 amRNSUpdate on 2024 Annual General Meeting outcome
21st Nov 20242:09 pmRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSUnaudited Interim Results for 6m ended 30 Sep 2024
19th Nov 20249:59 amRNSDirectorate Change
18th Nov 202412:07 pmRNSResult of General Meeting
23rd Oct 202412:00 pmRNSNotice of General Meeting
19th Sep 20246:11 pmRNSDirector/PDMR Shareholding
14th Aug 20241:37 pmRNSResult of Annual General Meeting
23rd Jul 20248:58 amRNSPublication of 2024 Annual Report and Accounts
12th Jul 20249:31 amRNSAnnual Financial Report and Notice of AGM
20th Jun 20247:00 amRNSPreliminary Results: year ended 31 March 2024
20th May 20247:00 amRNSUpdate on General Meeting voting outcome
14th Mar 20242:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.